Case Studies, Key Players, Tools
Who is Rolling out PrEP Now, How are They Doing it & Who is Funding it
USAID Microbicide Product Introduction Initiative (MPii)
The US Agency for International Development (USAID) is supporting five connected projects focused on introducing and providing access to ARV-based HIV prevention. These projects, which run from 2015-2020, focus on gender-based violence, drug resistance, creating demand, introducing new products, and models for delivering services. For a more detailed look at each of the five MPii projects, click here. And to see Tools & Resources from these projects, click here.
HIV Prevention Market Manager
Through the HIV Prevention Market Manager (PMM) Project, AVAC and CHAI seek to facilitate an efficient and effective rollout of HIV prevention products. The PMM works with partners across the prevention research to rollout spectrum to expand the portfolio of options and ensure appropriate products are available, accessible and used by those who need them most. Learn more.
For resources on end user work to date, click here.
Ongoing and Planned PrEP Demonstration Projects and Implementation Studies
Demonstration projects and implementation studies help countries learn about implementation issues so that the transition from research to product rollout and scale-up goes as smoothly as possible. Want to know about PrEP projects and studies happening right now? This summary table provides a downloadable spreadsheet with a detailed overview of ongoing studies in Africa, Europe, Latin America and the United States.
Get Tools From Demonstration Projects
Here you will find a list of Demonstration Projects and links to their tools. These tools range from educational and marketing materials to surveys and questionnaires to standard operating procedures. Use these tools to understand existing PrEP projects or adapt them for your own context!
Advocacy On the Ground
Explore our Country Updates, providing a snapshot of civil society work in a number of countries.
Get an in-depth look at the landscape in selected countries with country close-ups: Kenya, South Africa and Zimbabwe.
Launched in 2014, the DREAMS Initiative aims to reduce the incidence of HIV by 40 percent among adolescent girls and young women by 2020. It is a collaboration between the US President’s Emergency Plan for AIDS Relief (PEPFAR), the Bill & Melinda Gates Foundation, Girl Effect, Johnson & Johnson, Gilead Sciences and ViiV Healthcare.
The PEPFAR Scientific Advisory Board has endorsed PrEP and launched a DREAMS Innovation Challenge, to make more resources available for PrEP.
DREAMS is operating in ten countries, five of which have included PrEP for adolescent girls and young women in their country plans to address HIV.
Last updated January 31, 2017.